{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:51:02Z","timestamp":1790268662836,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbr.2025.115524","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:30:54Z","timestamp":1741048254000},"page":"115524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease"],"prefix":"10.1016","volume":"484","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-3849","authenticated-orcid":false,"given":"Ghassan M.","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdoon A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali K.","family":"Albuhadily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohaib G.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2025.115524_bib1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2022.07.002","article-title":"Neuropathologic changes provide insights into key mechanisms of Alzheimer disease and related dementia","volume":"192","author":"Plascencia-Villa","year":"2022","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbr.2025.115524_bib2","first-page":"1","article-title":"Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer\u2019s disease course","volume":"12","author":"Liguori","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbr.2025.115524_bib3","first-page":"7113","article-title":"Loneliness, cerebrovascular and Alzheimer\u2019s disease pathology, and cognition","volume":"20","author":"Lao","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.bbr.2025.115524_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-024-02789-9","article-title":"Association of quantitative histopathology measurements with antemortem medial temporal lobe cortical thickness in the Alzheimer\u2019s disease continuum","volume":"148","author":"Denning","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbr.2025.115524_bib5","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.24080","article-title":"Alzheimer disease-like neuropathologic changes in a geriatric baboon (Papio hamadryas)","volume":"25","author":"Harrison","year":"2024","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.bbr.2025.115524_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.14283\/jpad.2020.6","article-title":"PTI-125 reduces biomarkers of Alzheimer\u2019s disease in patients","volume":"7","author":"Wang","year":"2020","journal-title":"J. Prev. Alzheimer\u2019s. Dis."},{"key":"10.1016\/j.bbr.2025.115524_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/diagnostics14070704","article-title":"Neuropathology, neuroimaging, and fluid biomarkers in Alzheimer\u2019s disease","volume":"14","author":"Colvee-Martin","year":"2024","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbr.2025.115524_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ddr.22085","article-title":"Targeting \u03b17 nicotinic acetylcholine receptors and their protein interactions in Alzheimer\u2019s disease drug development","volume":"84","author":"Burns","year":"2023","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bbr.2025.115524_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.757515","article-title":"Calcium ions aggravate Alzheimer\u2019s disease through the aberrant activation of neuronal networks, leading to synaptic and cognitive deficits","volume":"14","author":"Guan","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3233\/JAD-210607","article-title":"Potential mechanisms underlying resistance to dementia in non-demented individuals with Alzheimer\u2019s disease neuropathology","volume":"87","author":"Kok","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbr.2025.115524_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/antiox10081231","article-title":"Linking oxidative stress and proteinopathy in Alzheimer\u2019s disease","volume":"10","author":"Sharma","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbr.2025.115524_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113481","article-title":"Role of RhoA\/ROCK signaling in Alzheimer\u2019s disease","volume":"414","author":"Cai","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2025.115524_bib13","series-title":"Protein Kinase Inhib","first-page":"409","article-title":"ROCKs as a potential drug target to combat Alzheimer\u2019s disease","author":"Ahmad","year":"2022"},{"key":"10.1016\/j.bbr.2025.115524_bib14","first-page":"99","article-title":"Rho-ROCK signaling in normal physiology and as a key player in shaping the tumor microenvironment","author":"Porazinski","year":"2020","journal-title":"Tumor Microenviron. Signal. Pathw. \u2013Part A."},{"key":"10.1016\/j.bbr.2025.115524_bib15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/21541248.2017.1364831","article-title":"Regulation of RhoA GTPase and novel target proteins for ROCK","volume":"11","author":"Choi","year":"2020","journal-title":"Small GTPases"},{"key":"10.1016\/j.bbr.2025.115524_bib16","doi-asserted-by":"crossref","first-page":"21901","DOI":"10.1038\/srep21901","article-title":"Spatio-temporal co-ordination of RhoA, Rac1 and Cdc42 activation during prototypical edge protrusion and retraction dynamics","volume":"6","author":"Martin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2025.115524_bib17","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/jcm9051328","article-title":"ROCK (RhoA\/Rho kinase) in cardiovascular\u2013renal pathophysiology: a review of new advancements","volume":"9","author":"Seccia","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bbr.2025.115524_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/21541248.2020.1840889","article-title":"Regulation and functions of the RhoA regulatory guanine nucleotide exchange factor GEF-H1","volume":"12","author":"Joo","year":"2021","journal-title":"Small GTPases"},{"key":"10.1016\/j.bbr.2025.115524_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/genes14020272","article-title":"Effect of the Rho-Kinase\/ROCK signaling pathway on cytoskeleton components","volume":"14","author":"Guan","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.bbr.2025.115524_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2022.08.012","article-title":"Role of RhoA and Rho-associated kinase in phenotypic switching of vascular smooth muscle cells: implications for vascular function","volume":"358","author":"Sawma","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbr.2025.115524_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0320-4","article-title":"Rho GTPases as therapeutic targets in Alzheimer\u2019s disease","volume":"9","author":"Aguilar","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bbr.2025.115524_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbrc.2008.05.153","article-title":"Rac1 changes the substrate specificity of \u03b3-secretase between amyloid precursor protein and Notch1","volume":"372","author":"Boo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbr.2025.115524_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/cells14020089","article-title":"Molecular mechanisms of Alzheimer\u2019s disease induced by amyloid-\u03b2 and tau phosphorylation along with RhoA activity: perspective of RhoA\/Rho-associated protein kinase inhibitors for neuronal therapy","volume":"14","author":"Ahn","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2025.115524_bib24","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1096\/fj.202000550RR","article-title":"Activation of FAK\/Rac1\/Cdc42-GTPase signaling ameliorates impaired microglial migration response to A\u03b242 in triggering receptor expressed on myeloid cells 2 loss-of-function murine models","volume":"34","author":"Rong","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bbr.2025.115524_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/JAD-2010-1203","article-title":"Altered distribution of RhoA in Alzheimer\u2019s disease and A\u03b2PP overexpressing mice","volume":"19","author":"Huesa","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.bbr.2025.115524_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101446","article-title":"Distinct dual roles of p-Tyr42 RhoA GTPase in tau phosphorylation and ATP citrate lyase activation upon different A\u03b2 concentrations","volume":"32","author":"Cap","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbr.2025.115524_bib27","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.1038\/ncomms8781","article-title":"HDAC6 and RhoA are novel players in Abeta-driven disruption of neuronal polarity","volume":"6","author":"Tsushima","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2025.115524_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s43556-021-00036-1","article-title":"G-protein coupled receptor, PI3K and Rho signaling pathways regulate the cascades of Tau and amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"2","author":"Desale","year":"2021","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbr.2025.115524_bib29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/brain\/awm260","article-title":"The \u03b2-amyloid protein of Alzheimer\u2019s disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism","volume":"131","author":"Petratos","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbr.2025.115524_bib30","doi-asserted-by":"crossref","first-page":"13322","DOI":"10.1038\/s41598-020-70153-4","article-title":"Signaling via the p75 neurotrophin receptor facilitates amyloid-\u03b2-induced dendritic spine pathology","volume":"10","author":"Patnaik","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbr.2025.115524_bib31","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1523\/JNEUROSCI.2983-18.2018","article-title":"Pyk2 signaling through Graf1 and RhoA GTPase is required for amyloid-\u03b2 oligomer-triggered synapse loss","volume":"39","author":"Lee","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105278","article-title":"NMDA mediates disruption of blood-brain barrier permeability via Rho\/ROCK signaling pathway","volume":"154","author":"Yu","year":"2022","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbr.2025.115524_bib33","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.3390\/molecules23092371","article-title":"RhoA\/ROCK-2 pathway inhibition and tight junction protein upregulation by catalpol suppresses lipopolysaccaride-induced disruption of blood-brain barrier permeability","volume":"23","author":"Feng","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbr.2025.115524_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/alz.066991","article-title":"Spatial dysregulation of Rho GTPases in Alzheimer\u2019s Disease brain in human and in transgenic mouse model","volume":"18","author":"Akhtar","year":"2022","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.bbr.2025.115524_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbr.2012.09.043","article-title":"Behavioral effects of Rho GTPase modulation in a model of Alzheimer\u2019s disease","volume":"237","author":"Musilli","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2025.115524_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/jnc.14130","article-title":"Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer\u2019s disease","volume":"144","author":"Lai","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbr.2025.115524_bib37","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/14656566.2021.1912013","article-title":"An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage","volume":"22","author":"Maruhashi","year":"2021","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbr.2025.115524_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071648","article-title":"ROCK inhibition as potential target for treatment of pulmonary hypertension","volume":"10","author":"Montagnoli","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbr.2025.115524_bib39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.2174\/1871530322666220606090801","article-title":"Reducing proteoglycan synthesis and NOX Activity by ROCK inhibitors: therapeutic targets in atherosclerosis","volume":"22","author":"Babaahmadi-Rezaei","year":"2022","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.bbr.2025.115524_bib40","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bbr.2025.115524_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pupt.2017.08.002","article-title":"Effects of fasudil on pulmonary hypertension in clinical practice","volume":"46","author":"Zhang","year":"2017","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.bbr.2025.115524_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0091270006293767","article-title":"Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract","volume":"47","author":"Hinderling","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbr.2025.115524_bib43","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/a-1879-3111","article-title":"The therapeutic role of Rho Kinase inhibitor, fasudil, on pulmonary hypertension; a systematic review and meta-analysis","volume":"73","author":"Abedi","year":"2023","journal-title":"Drug Res."},{"key":"10.1016\/j.bbr.2025.115524_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577284","article-title":"Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer\u2019s disease mice via the downregulation of TLR4\/Myd88\/NF-\u03baB pathway","volume":"346","author":"Guo","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbr.2025.115524_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5114\/fn.2021.105130","article-title":"Fasudil ameliorates cognitive deficits, oxidative stress and neuronal apoptosis via inhibiting ROCK\/MAPK and activating Nrf2 signalling pathways in APP\/PS1 mice","volume":"59","author":"Wei","year":"2021","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.bbr.2025.115524_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2018.05.024","article-title":"Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer\u2019s disease: involvement of PI3-kinase, eNOS and NF\u03baB","volume":"351","author":"Kumar","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2025.115524_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1871527315666160711104719","article-title":"Multitarget therapeutic effect of fasudil in APP\/PS1transgenic mice","volume":"16","author":"Yu","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bbr.2025.115524_bib48","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fnagi.2018.00216","article-title":"Fasudil in combination with bone marrow stromal cells (BMSCs) attenuates Alzheimer\u2019s disease-related changes through the regulation of the peripheral immune system","volume":"10","author":"Yu","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib49","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s11011-019-00487-0","article-title":"The Rho kinase inhibitor fasudil attenuates A\u03b2(1-42)-induced apoptosis via the ASK1\/JNK signal pathway in primary cultures of hippocampal neurons.","volume":"34","author":"Gao","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2025.115524_bib50","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1523\/JNEUROSCI.1409-18.2018","article-title":"Synaptotoxicity in alzheimer\u2019s disease involved a dysregulation of actin cytoskeleton dynamics through Cofilin 1 phosphorylation","volume":"38","author":"Rush","year":"2018","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib51","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jalz.2017.09.008","article-title":"Amyloid \u03b2 synaptotoxicity is Wnt-PCP dependent and blocked by fasudil","volume":"14","author":"Sellers","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bbr.2025.115524_bib52","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31083\/j.jin.2020.04.243","article-title":"Fasudil reduces \u03b2-amyloid levels and neuronal apoptosis in APP\/PS1 transgenic mice via inhibition of the Nogo-A\/NgR\/RhoA signaling axis","volume":"19","author":"Guo","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib53","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s11011-024-01395-8","article-title":"Exosomal MicroRNAs modulate the cognitive function in fasudil treated APPswe\/PSEN1dE9 transgenic (APP\/PS1) mice model of Alzheimer\u2019s disease","volume":"39","author":"Yan","year":"2024","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.bbr.2025.115524_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1323563","article-title":"Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer\u2019s disease","volume":"16","author":"Collu","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311219","article-title":"Neurodegenerative disease associated pathways in the brains of triple transgenic alzheimer\u2019s model mice are reversed following two weeks of peripheral administration of fasudil","volume":"24","author":"Killick","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbr.2025.115524_bib56","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/0115672050317608240531130204","article-title":"ROCK inhibitor Fasudil Attenuates neuroinflammation and associated metabolic dysregulation in the Tau Transgenic Mouse Model of Alzheimer\u2019s disease","volume":"21","author":"Ouyang","year":"2024","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bbr.2025.115524_bib57","first-page":"2435","article-title":"Efficacy of Rho kinase inhibitor on cognitive impairment induced by chronic cerebral hypoperfusion in rats","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbr.2025.115524_bib58","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fneur.2019.00293","article-title":"ROCK-ALS: protocol for a randomized, placebo-controlled, double-blind Phase IIa trial of safety, tolerability and efficacy of the Rho Kinase (ROCK) inhibitor fasudil in amyotrophic lateral sclerosis","volume":"10","author":"Lingor","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.bbr.2025.115524_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1308577","article-title":"Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson\u2019s disease (ROCK-PD)","volume":"16","author":"Wolff","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bbr.2025.115524_bib60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40263-024-01070-7","article-title":"SAFE-ROCK: A Phase I Trial of an oral application of the ROCK inhibitor fasudil to assess bioavailability, safety, and tolerability in healthy participants","volume":"38","author":"Wolff","year":"2024","journal-title":"CNS Drugs"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643282500110X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016643282500110X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:02:28Z","timestamp":1741669348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016643282500110X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":60,"alternative-id":["S016643282500110X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115524","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2025.115524","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115524"}}